
Ademar Pharma Private Limited
About Ademar Pharma Private Limited
Data last updated:
Ademar Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 20 April 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U85100TG2016PTC109147. Its GSTIN is 36AAOCA3319B1ZZ (Telangana).
The company has an authorised share capital of ₹9 Lakh and a paid-up capital of ₹6 Lakh. It is led by directors including Ambati Satya Naga Venkata Siva Prasad and Sherifuddin Sheriff Shaik.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at House No.52(Old No.8 – 2 – Ss4/4A) Road No.4 Banjara Hills, Hyderabad, Telangana, India – 500034.
As per the financials filed for FY 2019, the company reported a revenue of ₹32.69 Lakh, a growth of 23% compared to the previous year. For the same year it recorded a net loss of ₹53,317 (net margin -1.6%) and EBITDA of -₹33,241 (EBITDA margin -1%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Ademar Pharma Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressHouse No.52(Old No.8 – 2 – Ss4/4A) Road No.4 Banjara Hills, Hyderabad, Telangana, India – 500034
- IndustryHealthcare, Medical & Laboratory Equipment, Medical Consumables & Supplies
To see the full contact details of Ademar Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ademar Pharma is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Ademar Pharma Private Limited, buy the company report.
Financials of Ademar Pharma Private Limited
FY 2019 filings availableAdemar Pharma Private Limited reported revenue of ₹32.69 Lakh (up 23% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue rose 23% in the latest year. EBITDA rose 88% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹33,241 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹53,317 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -1% | ||
| Net Profit Margin | -1.6% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Ademar Pharma Private Limited, buy the company report.
Board of directors of Ademar Pharma Private Limited
Ademar Pharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ambati Satya Naga Venkata Siva Prasad | Director | 26 Jul 2017 | 9 Years 3 Months | Current |
| Sherifuddin Sheriff Shaik | Director | 20 Apr 2016 | 10 Years 7 Months | Current |
| Syed Rafi Ahmed | Director | 20 Apr 2016 | 10 Years 7 Months | Current |
Auditor
Ademar Pharma Private Limited is audited by S K LAHOTI ASSOCIATES for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S K LAHOTI ASSOCIATES | FY 2018 | 001819S |
Shareholding
The shareholding of Ademar Pharma Private Limited is on record for 2 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Ademar Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ademar Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ademar Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ademar Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAOCA3319B1ZZ | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Ademar Pharma Private Limited, buy the company report.
Recent activity
Ademar Pharma Private Limited has 4 board changes on record since 2016: 3 appointments and 1 cessation. The latest: Sherifuddin Sheriff Shaik ceased to be Director on 06 Dec 2019.
Frequently asked questions
Ademar Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 20 April 2016 (10+ years old) and is registered under CIN U85100TG2016PTC109147.
Ademar Pharma has 3 current directors:
- Ambati Satya Naga Venkata Siva Prasad - Director
- Sherifuddin Sheriff Shaik - Director
- Syed Rafi Ahmed - Director
The latest financial statements of Ademar Pharma on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Ademar Pharma is 36AAOCA3319B1ZZ, registered in Telangana.
The CIN (Corporate Identification Number) of Ademar Pharma is U85100TG2016PTC109147. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ademar Pharma was incorporated on 20 April 2016, making it 10+ years old. It is registered with the Registrar of Companies, Hyderabad.
Sherifuddin Sheriff Shaik ceased to be Director on 06 Dec 2019. Ambati Satya Naga Venkata Siva Prasad was appointed as Director on 26 Jul 2017. Sherifuddin Sheriff Shaik was appointed as Director on 20 Apr 2016. Ademar Pharma has 4 board changes on record in total.
The registered office of Ademar Pharma is at House No.52Old No.8 – 2 – Ss44A Road No.4 Banjara Hills, Hyderabad, Telangana, India – 500034.
Ademar Pharma operates in the healthcare industry, in the medical and laboratory equipment segment.
The compliance status of Ademar Pharma is compliant as of 26 July 2026. The company is actively filing with the Registrar of Companies.

